0001096906-19-000247.txt : 20190619 0001096906-19-000247.hdr.sgml : 20190619 20190619170057 ACCESSION NUMBER: 0001096906-19-000247 CONFORMED SUBMISSION TYPE: RW PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20190619 DATE AS OF CHANGE: 20190619 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SPRING PHARMACEUTICAL GROUP, INC. CENTRAL INDEX KEY: 0000847464 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 652954561 STATE OF INCORPORATION: FL FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: RW SEC ACT: SEC FILE NUMBER: 333-226179 FILM NUMBER: 19906611 BUSINESS ADDRESS: STREET 1: 11 QUANXING ROAD STREET 2: SHANDONG PROVINCE CITY: SICHUI STATE: F4 ZIP: 273200 BUSINESS PHONE: 86-537-4268278 MAIL ADDRESS: STREET 1: 11 QUANXING ROAD STREET 2: SHANDONG PROVINCE CITY: SICHUI STATE: F4 ZIP: 273200 FORMER COMPANY: FORMER CONFORMED NAME: China YCT International Group, Inc. DATE OF NAME CHANGE: 20080114 FORMER COMPANY: FORMER CONFORMED NAME: itLinkz Group, Inc. DATE OF NAME CHANGE: 20070406 FORMER COMPANY: FORMER CONFORMED NAME: MEDICAL TECHNOLOGY & INNOVATIONS INC /FL/ DATE OF NAME CHANGE: 19960118 RW 1 spring.htm REGISTRATION WITHDRAWAL

Spring Pharmaceutical Group, Inc.
c/o Shandong Spring Pharmaceutical
Economic Development Zone
Gucheng Road
Sishui County Shandong Province
People's Republic of China



June 19, 2019

VIA EDGAR
 
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-6010

Re:
Spring Pharmaceutical Group, Inc.

(formerly China YCT International Group, Inc.)

Withdrawal of Registration Statement on Form S-1

(File No. 333-226179)
 
Ladies and Gentlemen:
 
Pursuant to Rule 477 of Regulation C under the Securities Act of 1933, as amended, Spring Pharmaceutical Group, Inc. (formerly China YCT International Group, Inc.) (the “Registrant”) hereby respectfully requests that the Securities and Exchange Commission (the “Commission”) consent to the withdrawal of the Registration Statement on Form S-1 (File No. 333-226179), together with all exhibits and amendments thereto (collectively, the “Registration Statement”) effective as of the date hereof or as soon as practicable thereafter.
 
The Registration Statement has not been declared effective and no securities covered by the Registration Statement have been issued or sold. The Registrant has decided not to pursue the offering due to market conditions. Based on the foregoing, the Registrant submits that the withdrawal of the Registration Statement is consistent with the public interest and protection of investors.
 
In accordance with Rule 457(p) of Regulation C, the Registrant requests that all fees paid to the Commission in connection with the filing of the Registration Statement be credited for future use.
 
Please do not hesitate to contact the undersigned or Steven Schuster, Esq. of McLaughlin & Stern LLP, counsel to the Registrant, at (212) 448-6216 with any questions with regard to this matter.
 
Very truly yours,
 
/s/ Tinghe Yan

Tinghe Yan
Chief Executive Officer